---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-138870"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:46:44.564508+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inovio suspends ATM prospectus; raised $3.2M from 1.3M shares under program

## Summary
- On April 1, 2026, Inovio notified Oppenheimer of suspension and termination of the ATM prospectus from August 13, 2024.
- No further sales under the ATM program until a new prospectus is filed; the Sales Agreement remains in effect.
- As of April 1, 2026, Inovio had sold 1,319,644 shares for gross proceeds of $3.2 million under the ATM program.

## SEC filing metadata
- accession: 0001193125-26-138870
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312526138870/0001193125-26-138870-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312526138870/d107839d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-138870
- JSON: https://secwatch.observer/filing/0001193125-26-138870.json
- Plain text: https://secwatch.observer/filing/0001193125-26-138870.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.